A study survey on molnupiravir treatment in COVID-19 patients at home in Ninh Thuan province, Vietnam.

T Le-Huy, MG Balzanelli… - … Review for Medical …, 2024 - search.ebscohost.com
OBJECTIVE: Molnupiravir (MOV) is an oral antiviral drug that received use authorization in
Vietnam for the treatment of mild COVID-19 (F0). There was a need to develop alternative …
相关文章

A study survey on molnupiravir treatment in COVID-19 patients at home in Ninh Thuan province, Vietnam

T Le-Huy, MG Balzanelli, P Thai-Phuong… - … FOR MEDICAL AND …, 2024 - ricerca.uniba.it
Objective: Molnupiravir (MOV) is an oral antiviral drug that received use authorization in
Vietnam for the treatment of mild COVID-19 (F0). There was a need to develop alternative …

A study survey on molnupiravir treatment in COVID-19 patients at home in Ninh Thuan province, Vietnam.

T Le-Huy, MG Balzanelli, P Thai-Phuong… - European Review for …, 2024 - europepmc.org
Objective Molnupiravir (MOV) is an oral antiviral drug that received use authorization in
Vietnam for the treatment of mild COVID-19 (F0). There was a need to develop alternative …

A study survey on molnupiravir treatment in COVID-19 patients at home in Ninh Thuan province, Vietnam

T Le-Huy, MG Balzanelli… - … review for medical …, 2024 - pubmed.ncbi.nlm.nih.gov
Objective Molnupiravir (MOV) is an oral antiviral drug that received use authorization in
Vietnam for the treatment of mild COVID-19 (F0). There was a need to develop alternative …

A study survey on molnupiravir treatment in COVID-19 patients at home in Ninh Thuan province, Vietnam

T Le-Huy, MG Balzanelli, P Thai-Phuong… - Eur Rev Med …, 2024 - europeanreview.org
OBJECTIVE: Molnupiravir (MOV) is an oral antiviral drug that received use authorization in
Vietnam for the treatment of mild COVID-19 (F0). There was a need to develop alternative …

A study survey on molnupiravir treatment in COVID-19 patients at home in Ninh Thuan province, Vietnam

T Le-Huy, MG Balzanelli, P Thai-Phuong… - Eur Rev Med …, 2024 - europeanreview.org
OBJECTIVE: Molnupiravir (MOV) is an oral antiviral drug that received use authorization in
Vietnam for the treatment of mild COVID-19 (F0). There was a need to develop alternative …